References
- Bloom D. S., Stein M. G., Rosendorff C. Effects of hypertensive plasma on the responses of an isolated artery preparation to noradrenaline. Cardiovasc Res 1976; 10: 268–274
- Michelakis A. M., Mizukoshi H., Huang C., Murakami K., Inagami T. Further studies on the existence of a sensitizing factor to pressor agents in hypertension. J Clin Endocrinol Metab 1975; 41: 90–96
- Dahl L. K., Knudsen K. D., Iwai J. Humoral transmission of hypertension: Evidence from parabiosis. Circ Res 1969; 24/25(Suppl. I)21–33
- Zidek W., Heckmann U., Friemann J., Losse H., Vetter H. Role of kidney and adrenals in the humoral pathogenesis of primary hypertension. J Hypertension 1984; 2(suppl. 3)515–517
- Greenberg S., Gaines K., Sweatt D. Evidence for circulating factors as a cause of venous hypertrophy in spontaneously hypertensive rats. Am J Physiol 1981; 241: H421–H430
- Hirata Y., Tobian L., Simon G., Iwai J. Hypertension-producing factor in serum of hypertensive Dahl salt-sensitive rats. Hypertension 1984; 6: 709–716
- Wright G. L., McCumbee W. D. A hypertensive substance found in the blood of spontaneously hypertensive rats. Life Sci 1984; 34: 1521–1528
- McCumbee W. D., Wright G. L. Partial purification of a hypertensive substance from rat erythrocytes. Can J Physiol Pharmacol 1985; 63: 1321–1326
- Zidek W., Heckmann U., Losse H., Vetter H. Effects on blood pressure of cross circulation between spontaneously hypertensive and normotensive rats. Clin Exp Hypertens 1986; 8: 347–354
- Wessels F. Essentielle Hypertonie. Untersuchungen zur tiologie und Pathogenese. Urban & Schwarzenberg, München 1975
- Zidek W., Vetter H., Losse H. Intracellular mono- and divalent cations in spontaneously hypertensive rats of the Muenster strain. Hypertensive Mechanisms, W. Rascher, D. Clough, D. Ganten. Schattauer, Stuttgart 1982; 317–320
- Reid J. L., Elliott H. L. Methyldopa. Clinical pharmacology of antihypertensive drugs, A. E. Doyle. Handbook of Hypertension, Vol. 5, Elsevier, Amsterdam 1984; 92–112
- De Wardener H. E., Clarkson E. M. Concept of natriuretic hormone. Physiol Rev 1985; 65: 658–759
- De Wardener H. E., MacGregor G. A. The natriuretic hormone and hypertension. Lancet 1982; i: 1450–1454
- Krzesinski J. M., Godon J. P., Rorive G. L. Arguments for the presence of a Na-K- ATPase pump inhibitor in the plasma of uremic and essential hypertensive patients. Clin Exp Hypertens 1985; 7: 721–733
- De The H., Devynck M. A., Rosenfeld J. B., Pernollet M. G., Elghozi J. L., Meyer P. Plasma sodium pump inhibition in essential hypertension and normotensive subjects with hypertensive heredity. J Cardiovasc Pharmacol 1984; 6: S49–S54
- Hamlyn J. M., Ringel R., Schaeffer J., Levinson P. D., Hamilton B. P., Kovarski A. A., Blaustein M. P. A circulating inhibitor of (Na'+K') ATPase associated with essential hypertension. Nature 1982; 300: 650–652
- Haddy F. J., Pamnani M. B. Evidence for a circulating sodiumpotassium pump inhibitor in low renin hypertension. Clin Exp Hypertens 1985; 7: 633–645
- Devynck M. A., Pernollet M. G., Rosenfeld J. B., Meyer P. Measurement of digitalis-like compound in plasma: application in studies of essential hypertension. Brit Med J 1983; 287: 631–634
- Sagnella G. A., Markandu N. D., Shore A. C., McGregor G. A. Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet 1986; I: 179–181
- Kunes J., Stolba P., Pohlova I., Jelinek J., Zicha J. The importance of endogenous digoxin-like factors in rats with various forms of experimental hypertension. Clin Exp Hypertens 1985; 7: 707–720
- Lindner A., Kenny M., Meacham A. J. Effects of a circulating factor in patients with essential hypertension on intracellular free calcium in normal platelets. N Engl J Med 1987; 316: 509–513
- Iwai J., Knudsen K. D., Dahl L. K., Tassinari L. Effect of adrenalectomy on blood pressure in salt-fed, hypertension-prone rats: failure of hypertension to develop in absence of evidence of adrenal cortical tissue. J Exp Med. 1969; 129: 663–671
- Knudsen K. D., Iwai J., Heine M., Leitl G., Dahl L. K. Genetic influence on the development of renoprival hypertension in parabiotic rats. J Exp Med 1969; 130: 1353–1365
- Millett J. A., Holland S. M., Alaghband-Zadeh J., de Wardener H. E. Na-K-ATPase inhibiting and glucose-6-phosphate dehydrogenase-stimulating activity of plasma and hypothalamus of the Okamoto spontaneously hypertensive rat. J Endocrinol. 1986; 108: 69–73
- Lundberg J. M., Terenius L., Martling C. R., Tatemoto K., Polak J., Bloom S., Goldstein M. Neuropeptide Y (NPY)-like immunoreactivity in peripheral norad renergic neurones and effects of NPY on sympathetic function. Acta Physiol Scand 1982; 116: 525–528
- Allen J. M., Raine A. E.G., Ledingham J. G.G., Bloom S. R. Neuropeptide Y: a novel renal peptide with vasoconstrictor and natriuretic activity. Clin Sci 1985; 68: 373–377
- Bianchi G., Fox U., Di Francesco G. F., Giovanetti A. M., Pagetti D. Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. Clin Sci Mol Med 1974; 47: 435–448
- Dahl L. K., Heine M. Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ Res 1975; 36: 692–696
- Kawabe K., Watanabe T. X., Shiono K., Sokabe H. Influence of blood pressure on renal isografts between spontaneously hypertensive and normotensive rats utilizing the F1 hybrids. Jap Heart J 1979; 20: 886–894
- Curtis J. J., Luke R. G., Dustan H. P., Kashgarian M., Whelchel J. D., Jones P., Diethelm A. G. Remission of essential hypertension after renal transplantation. New Engl J Med 1983; 309: 1009–1015